Recent Updates
Recently added Catalysts
PTN Positive Sentiment Score: 65/100

Palatin to Report Second Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on February 15, 2024

Key Takeaway: Palatin Technologies, Inc. is set to announce its second quarter fiscal year 2024 operating results on February 15, 2024, prior to U.S. market opening. The company will hold a conference call and live audio webcast at 11:00 a.m. ET to discuss these results and provide updates on ongoing development programs. This event aims to give investors insights into the company's operational performance and strategic direction.

Market Sentiment Analysis

POSITIVE FACTORS

  • Upcoming conference call will provide insights into Q2 results.
  • Opportunity to discuss updates on development programs.
  • Company focuses on first-in-class medicines, targeting unmet medical needs.

Full Press Release Details

CRANBURY, N.J., Feb. 9, 2024 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its second quarter fiscal year 2024 operating results on Thursday, February 15, 2024, before the open of the U.S. financial markets.
Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on February 15, 2024, at 11:00 a.m. ET. The conference call will include a review of the company's operating results and an update on programs under development.
Schedule for the Operating Results Press Release, Conference Call / Audio Webcast
Q2 Fiscal Year 2024 Results Press Release 2/15/2024 at 7:30 a.m.ET
Q2 Fiscal Year 2024 Conference Call-Live US Toll Free Dial-In Number: International Dial-In Number: Participant Access Code: 2/15/2024 at 11:00 a.m. ET 1-888-506-0062 1-973-528-0011 397299
Q2 Fiscal Year 2024 Conference Call-Replay US Toll Free Dial-In Number: International Dial-In Number: Participant Access Code: 2/15/2024-2/29/2024 1-877-481-4010 1-919-882-2331 49945
The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com or by clicking here.
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com and follow Palatin on Twitter at @PalatinTech.
SOURCE Palatin Technologies, Inc.

21 %

more press release views with

Frequently Asked Questions

When will Palatin announce its Q2 fiscal results?

Palatin will announce its Q2 fiscal results on February 15, 2024.

What time is the conference call on February 15, 2024?

The conference call is set for 11:00 a.m. ET on February 15, 2024.

How can I access the audio webcast of the conference call?

The webcast can be accessed in the 'Investors-Webcasts' section of Palatin's website.

What is Palatin's focus as a biopharmaceutical company?

Palatin develops first-in-class medicines targeting melanocortin receptor systems.

What marketing strategy does Palatin utilize?

Palatin aims to form collaborations with industry leaders for product commercialization.

Last updated: Feb 9, 2024